The Low DoseThe GLP-1 price desk
Briefing

Noom Med vs Ivím Health

$149/mo against $199/mo for tirzepatide. Which is worth it, and for whom.

Illustration of two objects on a balance scale

Updated 2026-09-18

Both sell tirzepatide. Noom Med costs $149 a month and Ivím Health costs $199, a difference of $50 a month or about $600 a year. The desk reads it as follows.

Noom Med is behaviour change alongside medication. Ivím Health is unlimited clinician access. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Noom Med advertises $149 and bills $149; Ivím Health advertises $199 and bills $199. Both gaps are the same size, so the advertised comparison happens to hold.

Side by side

NoomIvím
Advertised$149$199
Billed$149$199
Gapnonenone
Per year, billed$1,788$2,388

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

1 differences on the record. The others match.

NoomIvím
Medication included in the monthly priceNoYes

What each puts on the record: Noom Med

    Where it wins: The coaching is the actual product here and it is well built. Watch for: A $79 microdose programme is not the same treatment as 10 mg tirzepatide. Check the dose before comparing on price.

    What each puts on the record: Ivím Health

    • Includes holistic coaching, wellness masterclasses and a tracking app.
    • New patients are offered a complimentary 30-minute consultation.

    Where it wins: Unlimited clinician visits at a flat rate — unusual at this price. Watch for: Pharmacy sourcing is not published. Ask which pharmacy fills your prescription and whether it is 503A or 503B before starting.

    In each one’s favour

    Noom Med.

    • The coaching is the actual product here and it is well built.
    • Medication is included in the microdose tier rather than billed separately.

    Ivím Health.

    • Unlimited clinician visits at a flat rate — unusual at this price.
    • Weekly dose review rather than a fixed monthly escalation.

    Ivím Health scores higher overall at 4 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

    The desk’s call

    The board says Noom Med. What the board cannot say is whether the advertised figures you were shown elsewhere match these — check the gap row, because a listing that advertises low and bills high will beat an honest one in any comparison built on advertised prices.

    The verdict

    On the board, Noom Med at $149 a month is the more defensible choice on arithmetic alone. Ivím Health earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Noom Med and Ivím Health.

    How they sit against everyone else

    ProgrammeAdvertisedBilledGapVs board floor
    Coreage Rx$149$199+$50+$74/mo
    Trimi$125$125none—
    Ozari Health$125$125none—
    Fifty 410$133$133none+$8/mo

    More from the desk

    • Noom Med tirzepatide review

      Advertised at $149 and billed at $149 — no gap. Position 0 of 18 on our board.

    • Ivím Health tirzepatide review

      Advertised at $199 and billed at $199 — no gap. Position 6 of 18 on our board.

    • How to spot a bad seller

      The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.

    • The twelve-month cost

      Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.

    • Cheapest right now

      Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.

    Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure